Armata Pharmaceuticals, Inc. (ARMP)
USD 1.95
(-2.5%)
USD 1.95
(-2.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -47.42 Million | -32.48 Million | -23.57 Million | -18.27 Million | -15.58 Million | -9.38 Million |
| Net Income | -69.04 Million | -36.91 Million | -23.15 Million | -22.18 Million | -19.47 Million | -12.11 Million |
| Depreciation & Amortization | 972 Thousand | 892 Thousand | 1.16 Million | 1.11 Million | 1.35 Million | 389 Thousand |
| Deferred income taxes | -2.84 Million | -171 Thousand | -1.3 Million | -432 Thousand | -454 Thousand | -328 Thousand |
| Stock-based compensation | 938 Thousand | 3.1 Million | 2.88 Million | 3.47 Million | 4.27 Million | 478 Thousand |
| Change in working capital | -9.64 Million | 439 Thousand | -3.22 Million | -874 Thousand | -2.18 Million | 345 Thousand |
| Other non-cash items | 32.2 Million | 171 Thousand | 60 Thousand | 628 Thousand | 918 Thousand | 1.84 Million |
| Investing Cash Flow | -8.13 Million | -2.21 Million | -1.3 Million | -824 Thousand | 2.87 Million | -44 Thousand |
| Investments in PPE | -8.14 Million | -2.21 Million | -1.3 Million | -824 Thousand | -131 Thousand | -44 Thousand |
| Acquisitions | 10 Thousand | - | - | - | 3 Million | 65 Thousand |
| Investment purchases | - | - | - | - | - | -3.39 Million |
| Sales/Maturities of investments | - | - | - | - | - | 13.01 Million |
| Other Investing Activities | 10 Thousand | - | - | - | 3 Million | 9.68 Million |
| Financing Cash Flow | 53.98 Million | 44.01 Million | 25.51 Million | 23.21 Million | 8.97 Million | 12.45 Million |
| Debt repayment | -54.02 Million | - | - | -717 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -43 Thousand | - | - | - | - | - |
| Common Stock Issuance | 5000.00 | 44.39 Million | 26.31 Million | 22.89 Million | 9.97 Million | 12.24 Million |
| Other Financing Activities | -43 Thousand | -375 Thousand | -801 Thousand | 1.03 Million | -1 Million | 203 Thousand |
| Accounts receivables | - | 1.05 Million | -2.42 Million | -467 Thousand | - | - |
| Accounts payables | 39 Thousand | 3.66 Million | 184 Thousand | 544 Thousand | -1.37 Million | 343 Thousand |
| Inventory | - | -1.05 Million | 2.42 Million | 467 Thousand | - | - |
| Other working capital | -9.68 Million | -3.22 Million | -3.4 Million | -1.41 Million | -815 Thousand | 2000.00 |
| Cash at beginning of period | 14.85 Million | 11.48 Million | 10.84 Million | 6.73 Million | 10.46 Million | 5.13 Million |
| Cash at end of period | 13.52 Million | 20.81 Million | 11.48 Million | 10.84 Million | 6.73 Million | 8.15 Million |
| Capital Expenditure | -8.14 Million | -2.21 Million | -1.3 Million | -824 Thousand | -131 Thousand | -44 Thousand |
| Effect of forex changes on cash | 240 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -1.32 Million | 9.32 Million | 639 Thousand | 4.11 Million | -3.73 Million | 3.02 Million |
| Free Cash Flow | -55.56 Million | -34.69 Million | -24.87 Million | -19.09 Million | -15.71 Million | -9.42 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.98 Million | -25.02 Million | -69.04 Million | -19.84 Million | -31.16 Million | -3.54 Million |
| Depreciation & Amortization | 315 Thousand | 317 Thousand | 972 Thousand | 293 Thousand | 221 Thousand | 228 Thousand |
| Deferred income taxes | - | - | -2.84 Million | -419 Thousand | 3.86 Million | - |
| Stock-based compensation | 1.33 Million | 534 Thousand | 938 Thousand | 193 Thousand | -373 Thousand | 261 Thousand |
| Change in working capital | -661 Thousand | -1.69 Million | -9.64 Million | 557 Thousand | 92 Thousand | -2.96 Million |
| Other non-cash items | -17.53 Million | 17.93 Million | 32.2 Million | 11.11 Million | 17.67 Million | -6.03 Million |
| Investing Cash Flow | -1.36 Million | -250 Thousand | -8.13 Million | -2.39 Million | -3.51 Million | -222 Thousand |
| Investments in PPE | -1.36 Million | -250 Thousand | -8.14 Million | -2.4 Million | -3.51 Million | -222 Thousand |
| Acquisitions | - | - | 10 Thousand | 10 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 10 Thousand | 10 Thousand | - | - |
| Financing Cash Flow | 88 Thousand | 34.93 Million | 53.98 Million | -43 Thousand | 24.8 Million | -368 Thousand |
| Debt repayment | - | -34.88 Million | -54.02 Million | -45.03 Million | -24.8 Million | -368 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -43 Thousand | -43 Thousand | - | - |
| Common Stock Issuance | 88 Thousand | 42 Thousand | 5000.00 | -5000.00 | 5000.00 | - |
| Other Financing Activities | 88 Thousand | 42 Thousand | -43 Thousand | -43 Thousand | 24.8 Million | -368 Thousand |
| Accounts receivables | - | - | - | -679 Thousand | - | - |
| Accounts payables | -654 Thousand | -1.48 Million | 39 Thousand | 360 Thousand | -437 Thousand | 1.45 Million |
| Inventory | - | - | - | 679 Thousand | - | - |
| Other working capital | -7000.00 | -204 Thousand | -9.68 Million | 197 Thousand | 529 Thousand | -4.42 Million |
| Cash at beginning of period | 37.86 Million | 13.52 Million | 14.85 Million | 23.95 Million | 18.17 Million | 30.82 Million |
| Cash at end of period | 26.4 Million | 37.86 Million | 13.52 Million | 13.52 Million | 29.78 Million | 18.17 Million |
| Capital Expenditure | -1.36 Million | -250 Thousand | -8.14 Million | -2.4 Million | -3.51 Million | -222 Thousand |
| Effect of forex changes on cash | - | - | 240 Thousand | 104 Thousand | - | 12.91 Million |
| Net cash flow / Change in cash | -11.45 Million | 24.33 Million | -1.32 Million | -10.43 Million | 11.6 Million | -12.65 Million |
| Free Cash Flow | -11.54 Million | -10.83 Million | -55.56 Million | -10.5 Million | -13.19 Million | -12.28 Million |
603662
RISMA
6088
ABVX
FNMAL
JPSTF